<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02798146</url>
  </required_header>
  <id_info>
    <org_study_id>NCKH/CGRH -01-2016</org_study_id>
    <nct_id>NCT02798146</nct_id>
  </id_info>
  <brief_title>Early Luteal Progesterone Profile After hCG Triggering</brief_title>
  <official_title>The Early Luteal Progesterone Profile in IVF Patients Triggered With hCG - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vietnam National University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mỹ Đức Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vietnam National University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot-study will help characterize the serum progesterone profiles in IVF patients and&#xD;
      correlate progesterone levels to ovarian follicles obtained after stimulation with exogenous&#xD;
      gonadotropins.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The early luteal progesterone profile in IVF differs significantly from the progesterone&#xD;
      profile of the natural cycle, in which the peak is reached around the time of implantation.&#xD;
      With this non-invasive trial investigators wish to further explore the early luteal phase&#xD;
      profiles of progesterone and hCG in order to optimize current luteal phase support policies&#xD;
      in IVF and hopefully increase ongoing pregnancy rates.&#xD;
&#xD;
      Stimulation, monitoring, and oocyte pick-up will be performed according to the standard&#xD;
      procedure of the clinic. On the day of trigger with 5.000 IU hCG a blood sample will be drawn&#xD;
      prior to triggering for subsequent analysis. Moreover, all ovarian follicles on each side&#xD;
      equal to or above 11 mm will be registered. Oocyte pick-up and timing of the trigger bolus&#xD;
      will be performed according to the standard procedures of the unit.&#xD;
&#xD;
      A total 10 blood samples will be drawn during this trial - please see &quot;blood sampling&quot;. Blood&#xD;
      samples will be collected on the following days for subsequent analysis of LH, E2, hCG and&#xD;
      progesterone.&#xD;
&#xD;
      All embryos will be cryo-preserved for transfer in subsequent frozen/thaw embryo transfer&#xD;
      cycles.&#xD;
&#xD;
      Primary endpoint Serum concentrations of progesterone, LH, E2, and hCG during early luteal&#xD;
      phase.&#xD;
&#xD;
      Secondary endpoints The correlation between follicles ≥ 11 mm and progesterone in early&#xD;
      luteal phase&#xD;
&#xD;
      Data are analyzed using SPSS version 20 software. All tests are two tailed, and P&lt;0.05 is&#xD;
      considered statistically significant. Continuous variables are presented as mean +/- SD and&#xD;
      are tested by student's t-test. Categorical data are expressed as numbers and compared using&#xD;
      the Chi-square test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">April 11, 2017</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in serum concentrations of progesterone</measure>
    <time_frame>in 6 days after human chorionic gonadotropin injection</time_frame>
    <description>Blood samples are collected at ten points of time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in serum concentrations of luteinizing hormone</measure>
    <time_frame>in 6 days after hCG injection</time_frame>
    <description>Blood samples are collected at ten points of time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in serum concentrations of estradiol</measure>
    <time_frame>in 6 days after hCG injection</time_frame>
    <description>Blood samples are collected at ten points of time.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in serum concentrations of hCG</measure>
    <time_frame>in 6 days after hCG injection</time_frame>
    <description>Blood samples are collected at ten points of time.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of follicles larger than 11 millimeters</measure>
    <time_frame>on the day of hCG injection</time_frame>
    <description>Number of follicles are counted on ultrasound image.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>hormonal levels</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Blood samples are collected for analysis of LH, E2, hCG and progesterone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood collection</intervention_name>
    <description>Blood samples are collected on the following days after human chorionic gonadotropin (hCG) injection: Day 0, Day 1, Day 2, Day 3, Day 4, Day 5, Day 6</description>
    <arm_group_label>hormonal levels</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  IVF patients who meet the following criteria:&#xD;
&#xD;
          -  Freeze all cycle after hCG trigger&#xD;
&#xD;
          -  Age 18 - 38&#xD;
&#xD;
          -  Body Mass Index (BMI) &lt; 28kg/m2&#xD;
&#xD;
          -  Normal ovarian reserve, defined by Anti-Mullerian Hormone (AMH) &gt; 1.25 ng/ml or Antral&#xD;
             Follicle Count (AFC) ≥ 6 measured within two months prior to stimulation start&#xD;
&#xD;
          -  Receiving Gonadotropin Releasing Hormone Antagonist co-treatment during ovarian&#xD;
             stimulation&#xD;
&#xD;
          -  Agreement to participate in the study, and to disclose any medical events to the&#xD;
             investigator. The subject must be willing and able to comply with the protocol&#xD;
             requirements for the duration of the study.&#xD;
&#xD;
          -  Have given written informed consent with the understanding that the subject may&#xD;
             withdraw consent at any time without prejudice to future medical care.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous poor response (≤ 3 oocytes) after high dose FSH stimulation&#xD;
&#xD;
          -  Hyper-response defined as &gt;20 follicles ≥ 14 mm&#xD;
&#xD;
          -  Chronical medical conditions like Diabetes, Crohns disease, Thyroid disease, Hepatitis&#xD;
             B and Sexually Transmitted Diseases Simultaneous participation in an interventional&#xD;
             clinical trial.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>June 5, 2016</study_first_submitted>
  <study_first_submitted_qc>June 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2016</study_first_posted>
  <last_update_submitted>April 17, 2017</last_update_submitted>
  <last_update_submitted_qc>April 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vietnam National University</investigator_affiliation>
    <investigator_full_name>Manh Tuong Ho</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>in-vitro fertilization</keyword>
  <keyword>luteal phase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

